| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.24797 |
| P698 | PubMed publication ID | 22105599 |
| P50 | author | David L Thomas | Q89653947 |
| P2093 | author name string | Anna S F Lok | |
| John W Ward | |||
| Hashem B El-Serag | |||
| W Ray Kim | |||
| P2860 | cites work | Gaps in hospital policies and practices to prevent perinatal transmission of hepatitis B virus | Q37704856 |
| Is chronic hepatitis B being undertreated in the United States? | Q37818488 | ||
| Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States | Q43033283 | ||
| Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users | Q43039432 | ||
| Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection | Q43571174 | ||
| Improving the management of chronic disease at community health centers | Q43617545 | ||
| Hepatitis B virus infection among refugees resettled in the U.S.: high prevalence and challenges in access to health care | Q44689974 | ||
| Knowledge of hepatitis C screening and management by internal medicine residents: trends over 2 years | Q45080291 | ||
| Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey | Q45368706 | ||
| Estimating the number of births to hepatitis B virus-infected women in 22 states, 2006. | Q45369580 | ||
| Screening for hepatitis C virus in a health maintenance organization | Q45742048 | ||
| Outcomes of treatment for hepatitis C virus infection by primary care providers | Q24601722 | ||
| Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 | ||
| Chronic hepatitis B: update 2009 | Q29617409 | ||
| Telaprevir for previously untreated chronic hepatitis C virus infection | Q29619800 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Boceprevir for untreated chronic HCV genotype 1 infection | Q29620617 | ||
| Expanding access to hepatitis C virus treatment--Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care | Q34124635 | ||
| Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting. | Q34344995 | ||
| Predictors of treatment in patients with chronic hepatitis C infection - role of patient versus nonpatient factors | Q34719654 | ||
| Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection | Q34777639 | ||
| An epidemic in evolution: the need for new models of HIV care in the chronic disease era. | Q35078744 | ||
| San Francisco hep B free: a grassroots community coalition to prevent hepatitis B and liver cancer | Q35089793 | ||
| Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes. | Q36619642 | ||
| Economics of chronic hepatitis B and hepatitis C. | Q36909732 | ||
| Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program | Q37216987 | ||
| Limited uptake of hepatitis C treatment among injection drug users | Q37238205 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 307-315 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Report on a single-topic conference on "Chronic viral hepatitis--strategies to improve effectiveness of screening and treatment". | |
| P478 | volume | 55 |
| Q91269159 | Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B |
| Q38204368 | Benefit-risk assessment of new and emerging treatments for hepatitis C: focus on simeprevir and sofosbuvir |
| Q42249938 | Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment |
| Q34110725 | Characteristics and management of patients with chronic hepatitis B in an integrated care setting |
| Q36484185 | Dual-Routine HCV/HIV Testing: Seroprevalence and Linkage to Care in Four Community Health Centers in Philadelphia, Pennsylvania |
| Q35671645 | Efficacy of tenofovir disoproxil fumarate therapy in nucleoside-analogue naive Iranian patients treated for chronic hepatitis B. |
| Q36858873 | Efforts at the Frontlines: Implementing a Hepatitis C Testing and Linkage-to-Care Program at the Local Public Health Level |
| Q38581096 | Essential components in developing public policy to control viral hepatitis: lessons from Taiwan |
| Q36955116 | Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response |
| Q28088546 | Hepatitis B among Asian Americans: Prevalence, progress, and prospects for control |
| Q40047408 | Improving Hepatitis C Identification: Technology Alone Is Not the Answer. |
| Q57178901 | Incorporation of Social Determinants of Health in the Peer-Reviewed Literature: A Systematic Review of Articles Authored by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention |
| Q36699256 | Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies |
| Q36858878 | Integrating Routine HCV Testing in Primary Care: Lessons Learned from Five Federally Qualified Health Centers in Philadelphia, Pennsylvania, 2012-2014. |
| Q39436181 | Loss to follow-up in anti-HCV-positive patients in a Brazilian regional outpatient clinic |
| Q90560707 | Retracted: Electronic Clinical Decision Support Intervention to Increase Hepatitis C Screening and Linkage to Care Among Baby Boomers in Urban Safety Net Health Systems |
| Q41921814 | Social Determinants of Health Associated with HBV Testing and Access to Care among Foreign-born Persons Residing in the United States: 2009 - 2012. |
| Q35930606 | The Patient-Provider Relationship Is Associated with Hepatitis C Treatment Eligibility: A Prospective Mixed-Methods Cohort Study |
| Q38127616 | Treatment of children with chronic viral hepatitis: what is available and what is in store |
Search more.